Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human papillomavirus testing in cervical cancer screening.

Obstetrics and gynecology clinics of North America - 1 Jun 2013

Castle Philip E, Cremer Miriam

Abstract excerpt

Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Papillomavirus Vaccines
Share to Colposcopy
Share to Human Papillomavirus DNA Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Papanicolaou Test

Share to Practice Guidelines as Topic

Share to Uterine Cervical Dysplasia

Share to Vaginal Smears

Source

Identifiers

PMID: 23732037
DOI: 10.1016/j.ogc.2013.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human papillomavirus testing in cervical cancer screening.PMID 23732037Read ↗

Human papillomavirus testing and genotyping in cervical screening.Semantic proximity Read ↗

Human Papillomavirus in Cervical Cancer Screening: Important Role as BiomarkerSemantic proximity Read ↗

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer ScreeningSemantic proximity Read ↗

2013 Statement on Human Papillomavirus DNA Test UtilizationSemantic proximity Read ↗

Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource SettingsSemantic proximity Read ↗

Cost Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16, 18 VaccinationSemantic proximity Read ↗

HPV detection methods and genotyping techniques in screening for cervical cancerSemantic proximity Read ↗

Human papillomavirus status in cervical scrapes and biopsy specimens using the HPV genotyping DNA microarray.Semantic proximity Read ↗

New strategies for human papillomavirus-based cervical screening.Semantic proximity Read ↗

HPV testing in cervical screening.Semantic proximity Read ↗

Assessing feasibility and effectiveness of point-of-care limited HPV genotype tests in cervical cancer screening: a modelling studySemantic proximity Read ↗

Lower cost strategies for triage of human papillomavirus DNA‐positive womenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.